Eli Lilly and Company (LLY)

NYSE: LLY · IEX Real-Time Price · USD
777.96
-0.22 (-0.03%)
At close: Mar 28, 2024, 4:00 PM
776.50
-1.46 (-0.19%)
After-hours: Mar 28, 2024, 7:59 PM EDT
-0.03%
Market Cap 739.66B
Revenue (ttm) 34.12B
Net Income (ttm) 5.24B
Shares Out 950.77M
EPS (ttm) 5.80
PE Ratio 134.13
Forward PE 61.55
Dividend $5.20 (0.67%)
Ex-Dividend Date Feb 14, 2024
Volume 3,198,687
Open 780.32
Previous Close 778.18
Day's Range 776.44 - 793.67
52-Week Range 336.07 - 800.78
Beta 0.34
Analysts Strong Buy
Price Target 679.57 (-12.65%)
Earnings Date Apr 30, 2024

About LLY

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the... [Read more]

Sector Healthcare
Founded 1876
Employees 43,000
Stock Exchange NYSE
Ticker Symbol LLY
Full Company Profile

Financial Performance

In 2023, LLY's revenue was $34.12 billion, an increase of 19.56% compared to the previous year's $28.54 billion. Earnings were $5.24 billion, a decrease of -16.08%.

Financial Statements

Analyst Forecast

According to 23 analysts, the average rating for LLY stock is "Strong Buy." The 12-month stock price forecast is $679.57, which is a decrease of -12.65% from the latest price.

Price Target
$679.57
(-12.65% downside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Three-Stock Lunch: Meta, Disney, and Eli Lilly

Eva Ados, ERShares chief investment strategist, joins 'Power Lunch' to discuss plays for three stocks, including Meta Platforms, Disney, and Eli Lilly.

Other symbols: DISMETA
14 hours ago - CNBC Television

Hennion & Walsh's Kevin Mahn on his top stock picks: CRWD, MSFT, LLY, RYTM

Kevin Mahn, Hennion & Walsh Asset Management president and CIO, joins 'Squawk Box' to discuss the latest market trends, why he believes AI isn't the only game in town for the markets, and more.

Other symbols: MSFTCRWDRYTM
20 hours ago - CNBC Television

Here's Why Ozempic And Mounjaro Rivals Won't Topple Weight Loss Drugmakers Novo Nordisk And Eli Lilly Anytime Soon

The world is hooked on weight loss drugs and so is the pharmaceutical industry, but as Big Pharma's biggest players and upstart biotechs rush to join the booming market, experts tell Forbes the domina...

Other symbols: NVO
1 day ago - Forbes

Here's how much people are willing to spend on weight loss drugs, according to a new survey

Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly correlated to their annual income.

Other symbols: NVO
5 days ago - CNBC

Medicare allows coverage of Wegovy for heart patients

Older adults may now get Medicare coverage for the popular obesity drug Wegovy, so long as they're using it to cut their risk of serious heart problems and not for weight loss alone, according to new ...

Other symbols: NVO
7 days ago - Market Watch

Eli Lilly and Novo can 'coexist for awhile' in the weight-loss drug space, says BMO's Evan Seigerman

Evan Seigerman, BMO Capital, joins 'Fast Money' to discuss BMO's inaugural GLP-1 conference.

Other symbols: NVO
8 days ago - CNBC Television

A new study cites the health risks of intermittent fasting. Could it lift Ozempic sales?

A new medical study is raising concerns over whether intermittent fasting, a weight-loss method that's gained attention in recent years, could pose heart-health risks.

Other symbols: NVOWW
9 days ago - Market Watch

Should You Pick Eli Lilly Stock After A 4x Rise In Three Years?

Eli Lilly stock (NYSE: LLY) has seen phenomenal gains of 345% from levels of $170 in early January 2021 to around $755 now, vs. an increase of about 35% for the S&P 500 over this roughly three-year pe...

9 days ago - Forbes

Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time

Eli Lilly's powerful weight-loss drug Zepbound hit 77,590 new prescriptions in the U.S. for the week ending March 8, surpassing Novo Nordisk's rival obesity medicine Wegovy for the first time since it...

13 days ago - Reuters

Call of the Day: Eli Lilly

JP Morgan is hiking Eli Lilly's price target to $850. The Investment Committee debate it.

13 days ago - CNBC Television

Weight Loss Drugs Coming to Amazon

As more obesity treatments receive FDA approval, Eli Lilly is seeking new ways to get its weight loss products to the people. Get caught up on the latest news in under 60 seconds as Jenny Horne detail...

Other symbols: AMZN
15 days ago - Schwab Network

Lilly Picks Amazon Pharmacy to Dispense Diabetes and Obesity Meds

Drugmaker Eli Lilly has teamed with Amazon to deliver medications to patients' homes. The partnership, announced Wednesday (March 13), will see Amazon Pharmacy serve as a third-party dispensing partne...

Other symbols: AMZN
15 days ago - PYMNTS

Eli Lilly, Amazon Partner for Direct-to-Consumer Delivery of Zepbound, Other Drugs

Eli Lilly (LLY) and Amazon (AMZN) announced a partnership Wednesday that will allow Eli Lilly prescription drugs to be shipped through Amazon's online pharmacy, as Eli Lilly looks to expand its direct...

Other symbols: AMZN
15 days ago - Investopedia

Eli Lilly strikes deal with Amazon Pharmacy for home delivery of Zepbound, other drugs

Eli Lilly & Co. has tapped Amazon.com Inc.'s Amazon Pharmacy to provide home delivery of certain Lilly medicines, including obesity drug Zepbound, the companies said Wednesday.

Other symbols: AMZN
15 days ago - Market Watch

Amazon Will Now Deliver Eli Lilly Weight Loss Drug

The pharmaceutical giant has teamed up with Amazon Pharmacy to offer home delivery of certain medications through its drug-access platform.

Other symbols: AMZN
15 days ago - Barrons

Lilly partners with Amazon to deliver Zepbound and other drugs

Eli Lilly said on Wednesday it has brought on Amazon.com's pharmacy unit to deliver drug prescriptions sent to its direct-to-consumer service, LillyDirect.

Other symbols: AMZN
16 days ago - Reuters

Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients

Amazon Pharmacy second online pharmacy to partner with Eli Lilly's site, and could provide faster deliveries for certain patients.

Other symbols: AMZN
16 days ago - CNBC

Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Eli Lilly chairman and CEO Dave Ricks says the company is working on expanding its medicine supply as the global obesity rate increases. Speaking with Bloomberg's Caroline Hyde at the Economic Club of...

16 days ago - Bloomberg Markets and Finance

Next thing: weight loss funds in the works

Next thing: weight loss funds in the works.

Other symbols: NVO
17 days ago - CNBC Television

More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study

INDIANAPOLIS , March 10, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color and...

18 days ago - PRNewsWire

Eli Lilly's campaign seeks to resolve weight-loss drug misconceptions

Eli Lilly is launching a campaign aimed at informing consumers about the seriousness of diabetes as a disease and the appropriate use of its weight-loss-related drugs.

19 days ago - Fox Business

The Stock Market's Great Reshuffling

Apple, Tesla and Alphabet have receded, while Nvidia and Eli are ascendant.

Other symbols: AAPLGOOGGOOGLNVDATSLA
20 days ago - Barrons

Eli Lilly's Alzheimer's Drug Release Delayed for FDA Investigation

Shares of Eli Lilly & Co. (LLY) were down more than 2% Friday after the pharmaceutical company announced that the Food and Drug Administration (FDA) wants more information about its experimental Alzhe...

20 days ago - Investopedia

Committee stocks on the move: Costco, Eli Lilly, Netflix, Google and Gold

The Investment Committee discuss stocks in their portfolio.

20 days ago - CNBC Television

Bullish on LLY, AVGO, AAPL

Eli Lilly (LLY), Broadcom (AVGO), and Apple (AAPL) are today's big three stocks. Jessica Inskip and Ben Lichtenstein discuss the technical trends, as well as how to trade these names.

Other symbols: AAPLAVGO
20 days ago - Schwab Network